U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

Spatial transcriptomics reveal unnresolved wound repair as potential driver of PFA Ependymoma progression

(Submitter supplied) Childhood brain tumor ependymoma remains incurable in approximately 50 percent of cases. No oncogenic mechanism has been firmly established for the commonest ependymoma variant posterior fossa subgroup A (PFA), impeding clinical advances. Uncovering how heterogeneous cell types within the tumor microenvironment interact is crucial to a complete understanding of PFA disease progression. The underlying cellular components of the PFA tumor microenvironment have been revealed by single cell transcriptomics, identifying divergent epithelial differentiation and EMT lineages. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
14 Samples
Download data: H5, TIFF, TSV
Series
Accession:
GSE195661
ID:
200195661
2.

Ependymoma subpopulation lineages underlie clinical classification and outcome

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array; Expression profiling by high throughput sequencing
Platforms:
GPL24676 GPL570 GPL20301
95 Samples
Download data: CEL
Series
Accession:
GSE126025
ID:
200126025
3.

Ependymoma subpopulation lineages underlie clinical classification and outcome (scRNAseq data set)

(Submitter supplied) Ependymoma (EPN) is a brain tumor commonly presenting in childhood that remains fatal in the majority of children. Intra-tumoral cellular heterogeneity in bulk tumor samples significantly confounds our understanding of EPN biology, impeding development of effective therapy. We used single-cell RNA sequencing to identify four neoplastic cell subpopulations in posterior fossa EPN patient samples that underlie traditional subgroup classification and harbor divergent lineage trajectories and clinical outcomes. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platforms:
GPL20301 GPL24676
26 Samples
Download data: TSV
Series
Accession:
GSE125969
ID:
200125969
4.

Ependymoma subpopulation lineages underlie clinical classification and outcome (microarray data set)

(Submitter supplied) Introduction: single-cell RNA sequencing identified multiple subpopulations in childhood posterior fossa ependymoma. The contribution of individual neoplastic subpopulations to bulk tumor transcriptome-based molecular classification and patient outcome was estimated by deconvolution in a cohort of clinically-annotated primary and recurrent EPN samples. The abundance of EPN subpopulations was estimated in primary EPN samples and showed that the ratio of subpopulation fractions dictated assignment to the two main transcriptomic classification subgroups in childhood posterior fossa ependymoma. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
69 Samples
Download data: CEL
Series
Accession:
GSE125861
ID:
200125861
5.

Clinical and genetic diversity and recurrent CXorf67 mutations across distinct molecular subgroups of posterior fossa type A (PFA) ependymoma.

(Submitter supplied) Ependymomas are neuroepithelial tumors of the central nervous system (CNS), presenting in both adults and children but accounting for almost 10% of all pediatric CNS tumors and up to 30% of CNS tumors in children under 3 years (Bouffet et al., 2009; McGuire et al., 2009; Rodriguez et al., 2009). In children, most ependymomas arise in the posterior fossa, while most adult ependymomas present around the lower spinal cord and spinal nerve roots. more...
Organism:
Homo sapiens
Type:
Methylation profiling by array
Platforms:
GPL13534 GPL21145
675 Samples
Download data: IDAT
Series
Accession:
GSE104210
ID:
200104210
6.

Gene expression data from posterior fossa ependymomas

(Submitter supplied) We have discovered two major molecular subgroups of PFA molecular group posterior fossa ependymomas by DNA methylation profiling. These are also distinguished by gene expression profiling using Affymetrix U133v2 arrays with correspondence to data generated by DNA methylation profiling.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
39 Samples
Download data: CEL
Series
Accession:
GSE100240
ID:
200100240
7.

Gene expression data from ependymal tumor samples

(Submitter supplied) Ependymal tumors across age groups have been classified and graded solely by histopathology. It is, however, commonly accepted that this classification scheme has limited clinical utility based on its lack of reproducibility in predicting patient outcome. We aimed at establishing a reliable molecular classification using DNA methylation fingerprints and gene expression data of the tumors on a large cohort of 500 tumors. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
209 Samples
Download data: CEL
Series
Accession:
GSE64415
ID:
200064415
8.

Metabolic regulation of the epigenome drives lethal infantile ependymoma [Cut&Run]

(Submitter supplied) PFA (posterior fossa group A) ependymomas are a lethal glial malignancy of the hindbrain found in infants and toddlers. Lacking any highly recurrent somatic mutations, PFAs have been proposed as a largely epigenetically driven tumor type. An almost complete lack of model systems has inhibited discovery of novel PFA therapies. Both in vitro and in vivo, the PFA hypoxic microenvironment controls the availability of specific metabolites to diminish histone methylation, and to increase both histone demethylation and acetylation at H3K27. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL18573
4 Samples
Download data: BW
Series
Accession:
GSE146858
ID:
200146858
9.

Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma

(Submitter supplied) Posterior fossa type A (PFA) ependymomas are a lethal glial malignancy of the hindbrain found in babies and toddlers. Lacking any highly recurrent somatic mutations, PFAs have been proposed as a largely epigenetically driven tumor type. An almost complete lack of model systems has inhibited discovery of novel PFA therapies. Both in vitro and in vivo, the PFA hypoxic microenvironment controls the availability of specific metabolites to diminish histone methylation, and to increase both histone demethylation and acetylation at H3K27. more...
Organism:
Homo sapiens
Type:
Methylation profiling by genome tiling array
Platform:
GPL21145
10 Samples
Download data: IDAT
Series
Accession:
GSE146426
ID:
200146426
10.

RNAseq analysis of normal childhood brain tissue

(Submitter supplied) Normal brain RNAseq data provides a critical comparitor for evaluation of gene expression changes in childhood brain tumors.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
16 Samples
Download data: XLSX
Series
Accession:
GSE244124
ID:
200244124
11.

Heterogeneity within the PF-EPN-B subgroup

(Submitter supplied) Combined EPIC and 450k analysis across 212 posterior fossa ependymoma's classified as PFB using the Heidelberg Brain Tumour Classifier Methylation profiling across 212 posterior fossa PFB ependymoma's to discern molecular heterogeneity
Organism:
Homo sapiens
Type:
Methylation profiling by genome tiling array
Platforms:
GPL21145 GPL16304
212 Samples
Download data: IDAT, TXT
Series
Accession:
GSE117130
ID:
200117130
12.

A multicenter study of poor prognosis chromosome 1q gain and/or 6q loss in posterior fossa A ependymoma shows increased prevalence from 20% at diagnosis to 60% at first recurrence.

(Submitter supplied) Ependymoma (EPN) posterior fossa group A (PFA) has the highest rate of recurrence and the worst prognosis of all EPN types. At relapse, it is typically incurable even with re-resection and re-irradiation. The biology of recurrent PFA EPN remains largely unknown, which hinders clinical advances. In this large longitudinal multicenter study, we examined matched samples of primary and recurrent disease from PFA EPN patients (n=95) to investigate the biology of recurrence. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
14 Samples
Download data: CSV, MTX, TSV
Series
Accession:
GSE227644
ID:
200227644
13.

Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: a multicenter study

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing; Methylation profiling by array
4 related Platforms
291 Samples
Download data: IDAT
Series
Accession:
GSE226961
ID:
200226961
14.

Epigenetic methylation chip analysis of childhood ependymoma PFA subgroup patient samples [Infinium 450K Methylation Beadchip]

(Submitter supplied) DNA methylation analysis was perfomed using Infinium 450K Methylation BeadChip platform on 140 PFA ependymoma patient samples. Resulting .idat files were then uploaded to the molecularneuropathology.org classifier to obtain molecular subgroup and copy number variance. Idat files were batch normalized and background corrected using default settings of the R package ChAMP to obtain GpG methylation beta values for analysis of differentially methylated GpG regions.
Organism:
Homo sapiens
Type:
Methylation profiling by array
Platform:
GPL13534
140 Samples
Download data: IDAT, TXT
Series
Accession:
GSE226960
ID:
200226960
15.

RNAseq analysis of childhood posterior fossa subgroup A ependymoma

(Submitter supplied) Posterior fossa subgroup A (PFA) ependymoma is a brain tumor of childhood with a high rate of recurrence. Here we have performed RNAseq on a longitudinal cohort of patient samples obtained at presentation and at recurrence(s), in order to identify the biological correlates of treatment failure and tumor evolution.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platforms:
GPL16791 GPL24676
72 Samples
Download data: XLSX
Series
Accession:
GSE226957
ID:
200226957
16.

Epigenetic methylation chip analysis of childhood PFA ependymoma patient samples [EPIC Methylation]

(Submitter supplied) DNA methylation analysis was perfomed using Infinium EPIC Methylation BeadChip platform on 65 PFA ependymoma patient samples. Resulting .idat files were then uploaded to the molecularneuropathology.org classifier to obtain molecular subgroup and copy number variance. Idat files were batch normalized and background corrected using default settings of the R package ChAMP to obtain GpG methylation beta values for analysis of differentially methylated GpG regions.
Organism:
Homo sapiens
Type:
Methylation profiling by array
Platform:
GPL21145
65 Samples
Download data: IDAT, TXT
Series
Accession:
GSE226895
ID:
200226895
17.

Methylation profiling of subependymoma of the posterior fossa and ependymoma evolving from subependymoma

(Submitter supplied) Methylation analysis of subepndymoma of the posterior fossa
Organism:
Homo sapiens
Type:
Methylation profiling by genome tiling array
Platforms:
GPL21145 GPL13534
54 Samples
Download data: CSV, IDAT
Series
Accession:
GSE169265
ID:
200169265
18.

TULIPs decorate the three-dimensional genome of PFA ependymoma

(Submitter supplied) Hi-C and RNA-seq for a large cohort of pediatric brain tumors including ependymoma (PFA, PFB, Ste, spinal), medulloblastoma (G3, G4, SHH), high grade glioma (H3K27 and H3-WT), pilocytic astrocytoma, and more.
Organism:
Homo sapiens
Type:
Other; Genome binding/occupancy profiling by high throughput sequencing
Platforms:
GPL20795 GPL24676
160 Samples
Download data: BED, BEDGRAPH, BEDPE, BROADPEAK, BW, GTF, HIC, MCOOL, RDATA, TDF, TSV, WIG
Series
Accession:
GSE186599
ID:
200186599
19.

Pro-Inflammatory Cytokines Mediate the Epithelial-to-Mesenchymal-Like Transition of Pediatric Posterior Fossa Ependymoma

(Submitter supplied) Pediatric ependymoma is a devastating brain cancer marked by its relapsing pattern and lack of effective chemotherapies. This shortage of treatments is due to limited knowledge about ependymoma tumorigenic mechanisms. By means of single-nucleus chromatin accessibility and gene expression profiling of posterior fossa primary tumors and distal metastases, we reveal key transcription factors and enhancers associated with the differentiation of ependymoma tumor cells into tumor-derived cell lineages and their transition into a mesenchymal-like state. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing
Platforms:
GPL18573 GPL24676
15 Samples
Download data
Series
Accession:
GSE206580
ID:
200206580
20.

Pro-Inflammatory Cytokines Mediate the Epithelial-to-Mesenchymal-Like Transition of Pediatric Posterior Fossa Ependymoma (single-nucleus ATAC-seq)

(Submitter supplied) Pediatric ependymoma is a devastating brain cancer marked by its relapsing pattern and lack of effective chemotherapies. This shortage of treatments is due to limited knowledge about ependymoma tumorigenic mechanisms. By means of single-nucleus chromatin accessibility and gene expression profiling of posterior fossa primary tumors and distal metastases, we reveal key transcription factors and enhancers associated with the differentiation of ependymoma tumor cells into tumor-derived cell lineages and their transition into a mesenchymal-like state. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL24676
6 Samples
Download data: MTX, RDS, TSV
Series
Accession:
GSE206579
ID:
200206579
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=2|qty=2|blobid=MCID_6730bfaaa52b9b75d5201c98|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center